GlassScriptPhysician profile
Alex Olivera
NPI 1801250675
$7,761.86
in general payments reported to CMS, 2019-2025
19 companies · $785 in 2025
The $785 reported for 2025 was more than what 75% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $709 · 2020: $1,883 · 2021: $2,316 · 2022: $1,439 · 2023: $155 · 2024: $474 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $3,550.70 | 2019-2022 | |
| Arthrex, INC. | $1,377.84 | 2021 | |
| Smith+Nephew, INC. | $953.58 | 2019-2025 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Stryker Corporation | $494.54 | 2019-2025 | Prostep Mica |
| Organogenesis INC. | $444.36 | 2019-2025 | Matrix, Nushield, Apligraf |
| Integra Lifesciences Corporation | $162.43 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $160.31 | 2022-2025 | Nuzyra |
| Kerecis Limited | $126.64 | 2020-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Kci USA, INC. | $124.99 | 2019 | |
| Paragon 28, INC. | $104.07 | 2025 | Avitus Bone Graft Harvester |
| Abbvie INC. | $55.68 | 2021-2022 | |
| Orthofix Medical, INC. | $54.12 | 2024-2025 | Physio-Stim |
| Next Science LLC | $40.75 | 2023-2024 | Blastx, Xperience, Surgx |
| Musculoskeletal Transplant Foundation INC. | $25.19 | 2023 | |
| Ossio INC | $21.32 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $20.57 | 2020 | |
| Nevro Corp. | $18.95 | 2023 | Senza |
| Bioventus LLC | $14.45 | 2019 | |
| Biopro, INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Olivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.